Medication errors in psychiatry: A comprehensive review

CNS Drugs

Volumn 24, Issue 7, 2010, Pages 595-609

  Procyshyn, Ric M ^a   Barr, Alasdair M ^a   Brickell, Tracey ^a   Honer, William G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Medication errors; Psychiatric disorders

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

CHILD PSYCHIATRY; CLINICAL FEATURE; CLINICAL PHARMACY; ELECTRONIC PRESCRIBING; GERONTOPSYCHIATRY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; INCIDENCE; MEDICATION ERROR; MENTAL DEFICIENCY; MENTAL DISEASE; METABOLIC SYNDROME X; MONITORING; NURSING; PATIENT CARE; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; ROOT CAUSE ANALYSIS;

DRUG PRESCRIPTIONS; HUMANS; INCIDENCE; MEDICATION ERRORS; MENTAL DISORDERS; PATIENT COMPLIANCE; PREVALENCE; PSYCHOTROPIC DRUGS;

EID: 77953250685     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11533710-000000000-00000     Document Type: Review

References (96)

1. Bhalla N, Duggan C, Dhillon S. The incidence and nature of drug-related admissions to hospital. Pharm J 2003; 270: 583-586
2. Edwards IR, Biriell C. Harmonisation in pharmaco-vigilance. Drug Saf 1994; 10: 93-102
3. National Coordinating Council for Medication Error Re-porting and Prevention. Medication error index [online]. Available from URL: http://www.nccmerp.org [Accessed 2008 Apr 9]
4. National Prescribing Centre (NPCi). Reducing medication errors [online]. Available from URL: http://www.npci.org.uk/medicines-management/safety/errors/ library/5mg-rme.php [Accessed 2009 Nov 25]
5. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001; 58: 1126-1132
6. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 2004; 329: 15-19 (Pubitemid 38869995)
7. Maidment ID, Lelliott P, Paton C. Medication errors in mental healthcare: a systematic review. Qual Saf Health Care 2006; 15: 409-413
8. Maidment ID, Haw C, Stubbs J, et al. Medication errors in older people with mental health problems: a review. Int J Geriatr Psychiatry 2008; 23: 564-573
9. Kohn L, Donaldson M, editors. To err is human: building a safer health system. Washington, DC: Institute of Medicine, 1999
10. Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266: 2847-2851
11. Grasso BC, Genest R, Jordan CW, et al. Use of chart and record reviews to detect medication errors in a state psychiatric hospital. Psychiatr Serv 2003; 54: 677-681
12. Hayward TW, Kravitz HM, Grossman LS, et al. Predicting the 'revolving door' phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 1995; 152: 856-861
13. Doering S, Muller E, Kopcke W, et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull 1998; 24: 87-98
14. Mitchell AJ. High medication discontinuation rates in psychiatry: how often is it understandable? J Clin Psycho-pharmacol 2006; 26: 109-112
15. Mitchell AJ, Selmes T. Why don't patients take their medi-cine? Reasons and solutions in psychiatry. Adv Psychiatr Treat 2007; 13: 336-346
16. Ciraulo DA, Sands BF, Shader RI. Critical review of liabi-lity for benzodiazepine abuse among alcoholics. Am J Psychiatry 1998; 145: 1501-1506
17. Busto UE, Romach MK, Sellers EM. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. J Clin Psycho-pharmacol 1996; 16: 51-57
18. Barber N. Should we consider non-compliance a medical error? Qual Saf Health Care 2002; 11: 81-84
19. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther 2007; 29: 2477-2497
20. Fugh-Berman A. Herb-drug interactions. Lancet 2003; 355: 134-138
21. Skop BP, Finkelstein JA, Mareth TR, et al. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1995; 13: 605-607
22. D'Mello DA, Boltz MK, Msibi B. Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. Am J Drug Alcohol Abuse 2005; 21: 257-265
23. Young AS, Sullivan G, Duan N. Patient, provider, and treatment factors associated with poor-quality care for schizophrenia. Ment Health Serv Res 1999; l: 201-211
24. Krakowski MI, Kuntz M, Czobor P, et al. Long-term high dose neuroleptic treatment: who gets it and why? Hosp Community Psychiatry 2003; 44: 640-644
25. Dean B, Barber N, Schachter M. What is a prescribing error? Int J Qual Health Care 2000; 9: 232-237
26. Paton C, Gill-Banham S. Prescribing errors in psychiatry. Psychiatr Bull R Coll Psychiatr 2003; 27: 208-210
27. Haw C, Stubbs J. Prescribing errors at a psychiatric hospital. Pharm Pract 2003; 13: 64-66
28. Bates DW, Leape LL, Cullen DJ, et al. Effect of computer-ized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311-1316
29. Kaushal R, Shojania KG, Bates DW. Effects of computer-ized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163: 1409-1416
30. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995; 27: 435-443
31. Lesar T, Briceland L, Delcoure K, et al. Medication pre-scribing errors in a teaching hospital. JAMA 1990; 263: 2329-2334
32. Stubbs J, Haw C, Cahill C. Auditing prescribing errors in a psychiatric hospital: are pharmacist's interventions effective? Hospital Pharmacist 2004; 11: 203-206
33. Stubbs J, Haw C, Taylor D. Prescription errors in psy-chiatry: a multi-centre study. J Psychopharmacol 2006; 20: 553-561
34. Geffen J, Cameron A, Sorensen L, et al. Pro re nata medi-cation for psychoses: the knowledge and beliefs of doctors and nurses. Aust N Z J Psychiatry 2002; 36: 642-648
35. Birmingham L, McLelland N, Bradley C. The use of "as required" antimuscarinic medication for the treatment of antipsychotic induced side effects. Br J Forensic Pract 1999; 1: 11-15
36. Harrington M, Lelliott P, Paton C, et al. The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the United Kingdom. Psychiatr Bull R Coll Psychiatr 2002; 26: 414-418
37. Lowe-Ponsford F, Baldwin D. Off-label prescribing by psychiatrists. Psychiatr Bull R Coll Psychiatr 2000; 24: 415-417
38. Chen H, Reverse JH, Fincham JE, et al. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia Medicaid enrollees in 2001. J Clin Psychiatry 2006; 67: 972-982
39. Hodgson R, Belgamwar R. Off-label prescribing by psy-chiatrists. Psychiatr Bull R Coll Psychiatr 2006; 30: 55-57
40. US Pharmacopeia. USP quality review: use caution-avoid confusion (2001) [online]. Available from URL: http://www. usp.org/pdf/EN/patientSafety/qr762001- 03-01.pdf [Accessed 2008 May 12]
41. US FDA. MedWatch safety alerts for human medical pro-ducts: Tegretol-XR (carbamazepine extended-release) [online]. Available from URL: http://www.fda.gov/Safety/Med Watch/SafetyInformation/ SafetyAlertsforHumanMedical Products/ucm152631.htm [Accessed 2008 Apr 10]
42. US FDA. MedWatch safety alerts for human medical pro-ducts: ZyPREXA (olanzapine) [online]. Available from URL: http://www.fda.gov/Safety/MedWatch/ SafetyInfor mation/SafetyAlertsforHumanMedicalProducts/ucm164909. htm [Accessed 2008 Apr 10]
43. US FDA. MedWatch safety alerts for human medical pro-ducts: Seroquel (quetiapine fumarate) [online]. Available from URL: http://www.fda.gov/Safety/ MedWatch/Safety Information/SafetyAlertsforHumanMedicalProducts/ucm 171082.htm [Accessed 2008 Apr 10]
44. The Joint Formulary Committee. British national formulary 57. London: Pharmaceutical Press, 2009
45. US FDA. Drug safety medication errors [online]. Available from URL: http://www.fda.gov/Drugs/DrugSafety/Medica tionErrors/default.htm [Accessed 2008 Apr 8]
46. Rothschild JM, Mann K, Keohane CA, et al. Medication safety in a psychiatric hospital. Gen Hosp Psychiatry 2007; 29: 156-162
47. Dean B, Schachter M, Vincent C, et al. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002; 359: 1373-1378
48. Grasso BC, Genest R, Yung K, et al. Reducing errors in discharge medication lists by using personal digital assistants. Psychiatr Serv 2002; 53: 1325-1326
49. Maidment ID, Thorn A. A medication error reporting scheme: analysis of the first 12 months. Psychiatr Bull R Coll Psychiatr 2005; 29: 298-301
50. Ito H, Yamazumi S. Common types of medication errors on long-term psychiatric care units. Int J Qual Health Care 2003; 15: 207-212
51. Haw CM, Dickens G, Stubbs J. A review of medication administration errors reported in a large psychiatric hospital in the United Kingdom. Psychiatr Serv 2005; 56: 1610-1613
52. Dickens G, Doyle C, Calvert J. Reducing medication ad-ministration errors in learning disability nursing. Nurse Prescribing 2006; 4: 470-474
53. Haw C, Stubbs J, Dickens G. An observational study of medication administration errors in old-age psychiatric inpatients. Int J Qual Health Care 2007; 19: 210-216
54. Dickens G, Stubbs J, Haw C. Administering medication to older mental health patients (2007) [online]. Available from URL: http://www.nursingtimes. net/nursing-practice-clinical-research/administering-medication-to-older-mental- health-patients/201837.article [Accessed 2009 Sep 22]
55. Taylor D, Young C, Esop R, et al. Testing for diabetes in hospitalized patients prescribed antipsychotic drugs. Br J Psychiatry 2004; 185: 152-156
56. Mukherjee S, Decina P, Bocoloa V, et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996; 34: 68-73
57. Kohen D. Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry 2004; 184 Suppl. 47: S64-6
58. Smith M, Hopkins D, Peveler RC, et al. First-v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2008; 192: 406-411
59. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19 Suppl. 1: 1-93
60. Newcomer JW. Metabolic considerations in the use of anti-psychotic medications: a review of recent evidence. J Clin Psychiatry 2007; 68 Suppl. 1: 20-27
61. Kehoe RF, Mander AJ. Lithium treatment: prescribing and monitoring habits in hospital and general practice. Br Med J 1992; 304: 552-554
62. Glover KJ, Lawley D. How safe is lithium prescribing? Audit of a local prescribing framework and patient survey. Psychiatr Bull R Coll Psychiatr 2005; 29: 98-100
63. Morcos S, Francis SA, Duggan C. Where are the weakest links? A descriptive study of discrepancies in prescribing between primary and secondary sectors of mental health service provision. Psychiatr Bull R Coll Psychiatr 2002; 26: 371-374
64. Clarke NA. What the eye doesn't see: drugs psychiatrists and GPs don't know their patients are on. Psychiatri Bull R Coll Psychiatr 1993; 17: 469-470
65. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 2005; 165: 424-429
66. Gleason KM, Groszek JM, Sullivan C. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm 2004; 61: 1689-1695
67. Provonost P, Weast B, Schwartz M, et al. Medication re-conciliation: a practical tool to reduce the risk of medication errors. Am J Crit Care 2003; 18: 201-205
68. Boockvar K, Fishman E, Kyriacou CK, et al. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med 2004; 164: 545-550
69. Brown EL, Raue PJ, Mlodzianowski AE, et al. Transition to home care: quality of mental health, pharmacy, and medical history information. Int J Psychiatry Med 2006; 36: 339-349
70. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Int Med 2006; 166: 565-571
71. Gurwich EL. Comparison of medication histories acquired by pharmacists and physicians. AJHP 1983; 40: 1541-1542
72. Nester TM, Hale LS. Effectiveness of a pharmacists-acquired medication history in promoting patient safety. Am J Health Syst Pharm 2002; 59: 2221-2225
73. McFadzean E, Isles C, Moffat J, et al. Is there a role for a prescribing pharmacist in preventing prescribing error in a medical admission unit? Pharm J 2003; 370: 896-899
74. Lizer MH, Brackbill ML. Medication history reconciliation by pharmacists in an inpatient behavioral health unit. Am J Health Syst Pharm 2007; 64: 1087-1091
75. Hawkey CJ, Hodgson S, Norman A, et al. Effect of reactive pharmacy intervention on quality of hospital prescribing. Br Med J 1990; 300: 986-990
76. Dale A, Copeland R, Barton R. Prescribing errors on med-ical wards and the impact of clinical pharmacists. IJPP 2003; 1: 19-24
77. Healthcare Commission. Talking about medicines: a report on the management of medicines in trusts providing mental health services (2007) [online]. Available from URL: http://www.carequalitycommission.org.uk/-db/- documents/Talk ing-about-medicines-mht-report-tagged.pdf [Accessed 2009 Nov 25]
78. McKee J, Cleary S. High-risk, high-alert medication man-agement practices in a regional state psychiatric facility. Hosp Pharm 2007; 42: 323-330
79. Misner ED. Consequence of drug dose and risk from medi-cal error (2008) [online]. Available from URL: http://www. bmj.com/cgi/eletters/324/7346/1113 [Accessed 2008 Apr 11]
80. Antonow JA, Smith AB, Silver MP. Medication error re-porting: a survey of nursing staff. J Nurs Care Qual 2000; 15: 42-48
81. Leape LL. Error in medicine. JAMA 1994; 72: 1851-7
82. Bates DW. Patient safety forum: examining the evidence. Psychiatr Serv 2003; 54: 1599-1603
83. Conway JB, Hayes RM, Reiss T, et al. Patient safety forum: developing a strategic plan. Psychiatr Serv 2004; 55: 259-263
84. Raschke RA, Gollihare B, Wunderlich TA, et al. A com-puter alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998; 280: 1317-1320
85. Phillips J, Beam S, Brinkner A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1824-1829
86. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684-689
87. Mort JR, Aparasu RR. Prescribing potentially inappropri-ate psychotropic medications to the ambulatory elderly. Arch Int Med 2000; 160: 2825-2831
88. Aparasu RR, Fliginger SE. Inappropriate medication pre-scribing for the elderly by office-based physicians. Ann Pharmacother 1997; 31: 823-829
89. Aparasu RR, Sitzman SJ. Inappropriate prescribing for the elderly in the outpatient department setting. Am J Health Syst Pharm 1999; 56: 433-439
90. Nirodi P, Mitchell AJ. The quality of psycotropic drug pre-scribing in patients with psychiatric untis for the elderly. Aging Ment Health 2002; 6: 191-196
91. Furniss L, Burns A, Craig SKL, et al. Effects of a pharma-cist's medication review in nursing homes: randomized controlled trial. Br J Psychiatry 2000; 164: 563-567
92. Spinewine A, Swine C, Dhillon S, et al. Effect of a colla-borative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007; 55: 658-665
93. Stupalski KA, Russel GE. Reported medication errors in community residences for individuals with mental retardation: a quality review. Ment Retard 1999; 37: 139-146
94. Vincent C, Taylor-Adams S, Chapman J, et al. How to in-vestigate and analyse critical incidents: clinical risk unit and association of litigation and risk management protocol. BMJ 2000; 320: 777-781
95. Helmreich RL. On error management: lesson from aviation. Br Med J 2000; 320: 781-785
96. Dean B. Learning from prescribing errors. Qual Saf Health Care 2002; 11: 258-260